Soleus Capital Management, L.P.
Top Portfolio Positions
93 positions ·
$2,469,218,398 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
1,153,087 | $297,865,433 | 12.06% | |
| CELC |
Celcuity Inc.
Healthcare
|
1,284,378 | $146,598,904 | 5.94% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
4,029,319 | $133,853,977 | 5.42% | |
| PODD |
Insulet Corp
Healthcare
|
562,500 | $118,035,000 | 4.78% | |
| NVCR |
NovoCure Ltd
Healthcare
|
10,492,391 | $114,367,061 | 4.63% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
187,187 | $110,998,147 | 4.50% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
330,517 | $106,489,272 | 4.31% | |
| VCEL |
Vericel Corp
Healthcare
|
2,549,079 | $82,003,871 | 3.32% | |
| ALKS |
Alkermes plc.
Healthcare
|
1,970,864 | $69,689,751 | 2.82% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
820,243 | $63,076,686 | 2.55% |
Portfolio Trend
25 quarters · across all stocks
Holdings in ORGO
Shares Held
Position Value (USD)
19 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,903,703 | 10,085,951 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $51,727,226 | 9,985,951 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $51,195,769 | 12,131,699 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,176,664 | 12,343,351 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $53,906,476 | 12,478,351 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,951,603 | 12,484,876 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,862,045 | 11,839,876 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,253,071 | 11,518,954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,187,882 | 9,573,198 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,658,670 | 8,963,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,101,798 | 12,296,163 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,937,169 | 11,728,063 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,987,024 | 9,853,063 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,806,639 | 7,363,063 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,024,564 | 6,489,063 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,796,494 | 5,286,167 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,356,072 | 2,540,167 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,471,563 | 1,999,087 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,111,990 | 639,887 | Shares | Sole | 2021-11-15 | |
| No 13F history on record for this holder in this stock. | ||||||